Lessons from human genetic variants in the study of B-cell differentiation

Current Opinion in Immunology

Volumn 8, Issue 4, 1996, Pages 454-458

  Satterthwaite, Anne B ^a   Witte, Owen N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; PROTEIN TYROSINE KINASE;

B LYMPHOCYTE DIFFERENTIATION; COMBINED IMMUNODEFICIENCY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; IMMUNE DEFICIENCY; NONHUMAN; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; T LYMPHOCYTE; WISKOTT ALDRICH SYNDROME; X LINKED AGAMMAGLOBULINEMIA;

EID: 0030218169     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80029-X     Document Type: Article

References (67)

1. Rosen FS, Cooper MD, Wedgwood RJP. The primary immunodeficiencies. N Engl J Med. 333:1995;431-440.
2. Symons M, Derry JMJ, Karlak B, Jiang S, Lemahieu V, McCormick F, Francke U, Abo A. Wiskott - Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. of special interest Cell. 84:1996;723-734 This report shows that WASP is an effector of CDC42Hs and is involved in actin polymerization.
3. Rawlings DJ, Witte ON. The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation, and function. Semin Immunol. 7:1995;237-246.
4. Kerner JD, Appleby MW, Mohr RN, Chien S, Rawlings DJ, Maliszewski CR, Witte ON, Perlmutter RM. Impaired expansion of mouse B-cell progenitors lacking Btk. of outstanding interest Immunity. 3:1995;301-312 See annotation [5].
5. Khan WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, Rathbun G, Davidson L, Müller S, Kantor AB, Herzenberg LA, Rosen FS, Sideras P. Defective B-cell development and function in Btk-deficient mice. of outstanding interest Immunity. 3:1995;283-299 Along with [4], this paper demonstrates that Btk knockout mice have a phenotype similar to that of X-immunodeficient mice and less severe than that of XLA patients. This indicates that B-cell development is more dependent on Btk in humans than in mice.
6. Narendran A, Ramaden D, Tanaka T, Wu GE, Paige CJ. B-cell developmental defects in X-linked immunodeficiency. Int Immunol. 5:1993;139-144.
7. Bona C, Mond JJ, Paul WE. Synergistic genetic defect in B-lymphocyte function. J Exp Med. 151:1980;224-234.
8. Karagogeos D, Rosenberg N, Wortis HH. Early arrest of B-cell development in nude, X-linked immune-deficient mice. Eur J Immunol. 16:1986;1125-1130.
9. Cheng G, Ye Zheng-S, Baltimore D. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc Natl Acad Sci USA. 91:1994;8152-8155.
10. Yang W, Malek SN, Desiderio S. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo. J Biol Chem. 270:1995;20832-20840.
11. Saouaf SJ, Mahajan S, Rowley RB, Kut S, Fargnoli J, Burkhardt AL, Tsukada S, Witte ON, Bolen JB. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinase following B-cell antigen receptor surface engagement. Proc Natl Acad Sci USA. 91:1994;9524-9528.
12. Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, Fluckiger AC, Witte ON, Kinet JP. Activation of Btk by a phosphorylation mechanism initiated by Src family kinases. of special interest Science. 271:1996;822-825 See annotation [13].
13. Mahajan S, Fargnoli J, Burkhardt AL, Kut SA, Saouaf SJ, Bolen JB. Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase. of special interest Mol Cell Biol. 15:1995;5304-5311 This paper and [12] show that Btk can be activated by src-family kinases and suggest that Btk is downstream of src-family kinases in B-cell signal transduction pathways.
14. Park HP, Wahl M, Afar DA, Turck C, Rawlings DJ, Tam C, Scharenberg AS, Kinet J-P, Witte ON. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. of special interest Immunity. 4:1996;515-525 This paper demonstrates that the major autophosphorylation site of Btk is in the SH3 domain. Mutation of this site increases the ability of activated forms of Btk to transform fibroblasts, indicating that Btk signaling is modulated by phosphorylation at this site.
15. Li T, Tsukada S, Satterthwaite A, Havlik MH, Park H, Takatsu K, Witte ON. Activation of Bruton's tyrosine kinase (Btk) by a point mutation in its pleckstrin homology (PH) domain. of special interest Immunity. 2:1995;451-460 This report describes an activating mutation in the PH domain of Btk. This allele will be a useful tool for defining signaling pathways mediated by Btk.
16. Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. of outstanding interest Cell. 83:1995;301-311 See annotation [18].
17. Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Llic D, Mori S, Watanabe T, Yamamoto T. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. of outstanding interest Immunity. 3:1995;549-560 See annotation [18].
18. T in interleukin-5 receptor signaling. of outstanding interest J Exp Med. 182:1995;811-820 This paper, [16] and [17] describe studies using lyn- and fyn-deficient mice which indicate that these two src family kinases have at least some non-overlapping roles in B-cell development and function.
19. Cheng AM, Rowley B, Pao W, Hayday A, Bolen JB, Pawson T. Syk tyrosine kinase required for mouse viability and B cell development. of outstanding interest Nature. 378:1995;303-306 See annotation [20].
20. Turner M, Mee PJ, Costello PS, Williams O, Price AA, Duddy LP, Furlong MT, Geahlen RLG, Tybulewicz VLJ. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. of outstanding interest Nature. 378:1995;298-302 This paper, along with [19] shows that syk is critical for murine B-cell development beyond the pre-B cell stage.
21. Ferguson KM, Lemmon MA, Schlessinger J, Sigler PB. Structure of the high affinity complex of inositol triphosphate with a phospholipase C pleckstrin homology domain. Cell. 83:1995;1037-1046.
22. Yao L, Kawakami Y, Kawakami T. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA. 91:1994;9175-9179.
23. Langhans-Rajasekaran SA, Wan Y, Huang Xin-Y. Activation of Tsk and Btk tyrosine kinases by G protein βγ subunits. Proc Natl Acad Sci USA. 92:1995;8601-8605.
24. Touhara K, Inglese J, Pitcher JA, Shawi G, Lefkowitz RJ. Binding of G protein βγ-subunits to pleckstrin homology domains. J Biol Chem. 269:1994;10217-10220.
25. Tsukada S, Simon M, Witte O, Katz A. Binding of the βγ subunits of heterotrimeric G-proteins to the PH domain of Bruton's tyrosine kinase. Proc Natl Acad Sci USA. 91:1994;11256-11260.
26. Cory GOC, Lovering RC, Hinshelwood S, MacCarthy-Morrogh L, Levinsky RJ, Kinnon C. The protein product of the c-cbl protooncogene is phosphorylated after B-cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Exp Med. 182:1995;611-615.
27. Yoo CH, Lee J, Jongeward GD, Sternberg PW. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-bl. Science. 269:1995;1102-1105.
28. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 73:1993;145-157.
29. Leonard WJ, Noguchi M, Russell SM, McBride OW. The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor γ chain as a common γ chain, γc. Immunol Rev. 138:1994;61-86.
30. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:1994;2822-2830.
31. Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Friedmann M, Berg M, McVicar DW, Witthuhn BA, Silvennoinen O, et al. Interaction of IL-2Rβ and γc chains with JAK1 and JAK3: implications for X-SCID and X-CID. Science. 266:1994;1042-1045.
32. Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu Zhao-J, Oishi I, Silvennoinen O, Witthuhn BA, Ihle JN, Taniguchi T. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science. 266:1994;1045-1047.
33. Boussiotis VA, Barber DL, Nakarai T, Freeman GJ, Gribben JG, Bernstein GM, D'Andrea AD, Ritz J, Nadler LM. Prevention of T cell anergy by signaling through the γc chain of the IL-2 receptor. Science. 266:1994;1039-1042.
34. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone Thi-S, Noguchi M, Market ML, Buckley RH, et al. Mutation of JAK3 in a patient with SCID: essential role of JAK3 in lymphoid development. of outstanding interest Science. 270:1995;797-800 A patient with autosomal SCID similar to X-SCID is shown to have mutations in JAK3, indicating that JAK3 is a critical component of γc signaling pathways.
35. Nosaka T, Van Deursen JMA, Tripp RA, Theirfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN. Defective lymphoid development in mice lacking JAK3. of outstanding interest Science. 270:1995;800-802 See annotation [37].
36. Thomis DC, Gurniak CB, Tivol E, Ahrpe AH, Berg LJ. Defects in B-lymphocyte maturation and T-lymphocyte activation in mice lacking JAK 3. of outstanding interest Science. 270:1995;794-797 See annotation [37].
37. Park SY, Saijo K, Takahashi T, Osawa M, Arase H, Hirayama N, Miyake K, Nakauchi H, Shirasawa T, Saito T. Developmental defects of lymphoid cells in JAK3 kinase-deficient mice. of outstanding interest Immunity. 3:1995;771-782 Mice deficient in JAK3 described in in this paper and [35, 36] have a similar phenotype to γc knockout mice, indicating that JAK3 is a critical component of γc signaling pathways.
38. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET, et al. Defective lymphoid development in mice lacking expression of the comon cytokine receptor γ chain. of outstanding interest Immunity. 2:1995;223-238 See annotation [40].
39. Ohbo K, Suda T, Hashiyama M, Mantani A, Ikebe M, Miyakawa K, Moriyama M, Nakamura M, Katsuki M, Takahashi K, et al. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor γ chain. of outstanding interest Blood. 87:1996;956-967 See annotation [40].
40. DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. of outstanding interest Proc Natl Acad Sci USA. 92:1995;377-381 This paper, along with [38, 39], demonstrates that mutation of γc in mice blocks both T and B cell development. Humans lacking γc have normal numbers of B cells, indicating that mice are more dependent on γc than humans for B lymphopoiesis.
41. Von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a non-redundant cytokine. of outstanding interest J Exp Med. 181:1995;1519-1526 Mice deficient in IL-7, shown here, have a similar phoenotype to γc knockout mice. This suggests that the block in lymphoid development in γc-deficient mice is a result of lack of signaling by IL-7 and not the other cytokines whose receptors share γc.
42. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med. 180:1994;1955-1960.
43. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature. 352:1991;621-624.
44. Kühn R, Rajewsky K, Müller W. Generation and analysis of interleukin-4-deficient mice. Science. 254:1991;707-710.
45. Xu J, Foy TM, Laman JD, Elliott EA, Dunn JJ, Waldschmidt TJ, Elsemore J, Noelle RJ, Flavell RA. Mice deficient for the CD40 ligand. Immunity. 1:1994;423-431.
46. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kikutani H. The immune response in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1:1994;167-178.
47. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today. 15:1994;406-411.
48. Aversa G, Punnonen J, Carballido JM, Cocks BG, De Vries JE. CD40 ligand - CD40 interaction in Ig isotype switching in mature and immature human B cells. Semin Immunol. 6:1994;295-301.
49. Arpin C, Déchanet J, Kooten CV, Merville P, Grouard G, Brière F, Banchereau J, Liu Yong-J. Generation of memory B cells and plasma cells in vitro. of special interest Science. 268:1995;720-722 This report describes an in vitro system for driving late stages of B cell differentiation. CD40L drives the production of memory cells. Plasma cells are generated in the absence of CD40L.
50. Nakayama K, Nakayama K, Dustin LB, Loh DY. T - B cell interaction inhibits spontaneous apoptosis of mature lymphocytes in Bcl-2-deficient mice. J Exp Med. 182:1995;1101-1110.
51. Wang Z, Karras JG, Howard RG, Rothstein TL. Induction of bcl-x by CD40 engagement rescues slg-induced apoptosis in murine B cells. J Immunol. 155:1995;3722-3725.
52. Grillot DAM, Merino R, Pena JC, Fanslow WC, Finkelman FD, Thompson CB, Núñez G. bcl-x exhibits regulated expression during B-cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med. 183:1996;381-391.
53. Sarma V, Lin Z, Clark L, Rust BM, Tewari M, Noelle RJ, Dixit VM. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J Biol Chem. 270:1995;12343-12346.
54. Schattner EJ, Elkon KB, Yoo Dae-H, Tumang J, Krammer PH, Crow MK, Friedman SM. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med. 182:1995;1557-1565.
55. Garrone P, Neidhardt Eve-M, Garcia E, Galibert L, Van Kooten C, Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med. 182:1995;1265-1273.
56. Lens SMA, Tesselaar K, Den Drijiver BFA, Van Oers MHJ, Van Lier RAW. A dual role for both CD40-ligand and TNF-α in controlling human B cell death. J Immunol. 156:1996;507-514.
57. Lagresle C, Bella C, Daniel PT, Krammer PH, Defrance T. Regulation of germinal center B cell differentiation. J Immunol. 154:1995;5746-5756.
58. Rothstein TL, Wang JKM, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju Shyr T, Marshak-Rothstein A. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature. 374:1995;163-165.
59. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. of special interest Nature. 374:1995;470-473 See annotation [60].
60. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VLJ. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. of special interest Nature. 374:1995;467-470 This paper and [59] shows that vav is required for antigen receptor signaling, but not B cell development.
61. Taniuchi I, Kitamura D, Maekawa Y, Fukuda T, Kishi H, Watanabe T, Kishi H, Watanabe T. Antigen-receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking hs1 protein, a substrate of the antigen-receptor-coupled tyrosine kinases. EMBO J. 14:1995;3664-3678.
62. Hasbold J, Klaus GG. B cells from CBA/N mice do not proliferate following ligation of CD40. Eur J Immunol. 24:1994;152-157.
63. Cheng G, Cleary AM, Ye Zheng-S, Hong DI, Lederman S, Baltimore D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. of special interest Science. 267:1995;1494-1498 This report indicates that the CRAF1/TRAF1 family is required for CD40 signaling.
64. Mosialos G, Birkenbach M, Yalamanchili R, Van Arsdale T, Ware C, Kieff E. The Epstein - Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389-399.
65. Hu HM, O'Rourke K, Boguski MS, Dixit VA. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem. 269:1994;30069-30072.
66. Derry JMJ, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott - Aldrich syndrome. Cell. 78:1994;635-644.
67. Rivero-Lezcano OM, Marcilla A, Sameshima JH, Robbins KC. Wiskott - Aldrich syndrome protein physically associates with Nck through Src homology 3 domains. Mol Cell Biol. 15:1995;5725-5731.